| Literature DB >> 18510774 |
Hamideh M Esmaily1, Carl Savage, Rezagoli Vahidi, Abolghasem Amini, Mohammad Hossein Zarrintan, Rolf Wahlstrom.
Abstract
BACKGROUND: Continuing medical education (CME) is compulsory for physicians in Iran. Recent studies in Iran show that modifications of CME elements are necessary to improve the effectiveness of the educational programmes. Other studies point to an inappropriate, even irrational drug prescribing. Based on a needs assessment study regarding CME for general physicians in the East Azerbaijan province in Iran, rational prescribing practice was recognized as a high priority issue. Considering different educational methods, outcome-based education has been proposed as a suitable approach for CME. The purpose of the study was to obtain experts' consensus about appropriate educational outcomes of rational prescribing for general physicians in CME and developing curricular contents for this education.Entities:
Mesh:
Year: 2008 PMID: 18510774 PMCID: PMC2443123 DOI: 10.1186/1472-6920-8-33
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Potential learning outcomes as assessed through the Delphi process
| 1. Date of the prescription | 21 | 20 |
| 2. Name and age of the patient | 21 | 20 |
| 3. Name and identification number of Iranian Medical Council of the prescriber** | 21 | 20 |
| 4. Main complaint of the patient | 11 | 16 |
| 5. Legible hand writing | 20 | 20 |
| 6. Generic name of the drugs | 16 | 18 |
| 7. Administration form of drugs | 20 | 20 |
| 8. Strength of the drugs and dose frequency | 20 | 20 |
| 9. Adequate duration of treatment | 16 | 20 |
| 10. Latin abbreviation of terminology in drug use order | 12 | 17 |
| 11. Appropriate number of drugs | 16 | 20 |
| 12. To consider homogeneity of prescription per individual (all drugs prescribed pertain to the same individual) | 18 | 19 |
| 13. Not prescribing drugs with the same pharmacological effect | 14 | 19 |
| 14. Not prescribing drugs which have negative interactions with each other | 17 | 19 |
| 15. Appropriate number and amount of antibiotics | 19 | 20 |
| 16. Appropriate number of injections | 17 | 20 |
| 1. Contact telephone number of the prescriber | 17 | |
| 2. Refill information | 18 | |
| 3. Initial diagnosis | 15 | |
| 4. Time and manner of drug use | 17 | |
| 5. Necessary precautions | 16 | |
| 6. Necessary notifications about signals to continue or stop drug use | 13 | |
| 7. Notification about side effects of drugs in the prescription | 6 | |
| 8. Name of the foods which have negative interactions on drug efficacy and the treatment process | 8 | |
| 9. Appropriate no. of NSAID (Non-steroidal anti-inflammatory) drugs | 20 | |
| 10. Appropriate number of vitamins | 19 | |
* Sum of the number of respondents who answered "partly agree" and "totally agree".
** Compulsory in Iran
Rational prescribing outcomes and indicators for GP's CME programmes as agreed by an expert panel
| 1. Write the date of the prescription | 1. Date of the prescription |
| 2. Write the name of the patient | 2. Name of the patient |
| 3. Write the age of the patient | 3. Age of the patient |
| 4. Write the name and identification number of the Iranian Medical Council for the prescriber | 4. Name and identification number of Iranian Medical Council of the prescriber |
| 5. Write the contact telephone number of prescriber | 5. Contact telephone number of prescriber |
| 6. Write refill information | 6. Refill information |
| 7. Write the prescription clearly | 7. Legible hand writing |
| 8. Write the generic name of the drugs | 8. Generic names of drugs |
| 9. Write the administration form of the drugs | 9. Administration form of drugs |
| 10. Write the strength of the drugs (dose and dose frequency) | 10. Strength of the drugs |
| 11. Write the duration of treatment | 11. Treatment duration |
| 12. Use the Latin abbreviation of terminology in drug use order | 12. Use Latin abbreviation terminology |
| 13. Write the time and manner of drug use | 13. Time and manner of drug use |
| 14. Write the necessary precautions | 14. Necessary precautions |
| 15. Prescribe the appropriate number of drugs | 15. Appropriate number of drugs |
| 16. Consider homogeneity of prescription per individual (all drugs prescribed pertain to the same individual) | 16. Homogeneity of prescriptions |
| 17. Avoid prescribing drugs with the same pharmacological effect | 17. Number of drugs in the same pharmacological group |
| 18. Avoid prescribing drugs which have negative interactions with each other | 18. Number of interactive drugs per prescription |
| 19. Prescribe the appropriate number and amount of antibiotics | 19. Number and amount of antibiotics per prescription and proportion of antibiotics prescribed |
| 20. Prescribe the appropriate number of injections | 20. Number of injections per prescription and proportion of injections prescribed |
| 21. Prescribe the appropriate number of Anti-Inflammatory Agents [Corticosteroids and Non-steroidal anti-inflammatory drugs (NSAID)] | 21. Appropriate number of Anti-Inflammatory Agents [Corticosteroids and Non-steroidal anti-inflammatory drugs (NSAID)] |
Curricular content for the programme on rational prescribing as developed by teams of CME trainers.
| History of prescription writing | Value of taking culture samples for infections |
| Classification of drugs | Assessment of infectious organisms |
| Definition and format | Importance of host factors in selection of |
| Elements of prescription writing | antibiotics |
| Measurements | Adherence to correct indications |
| Mistakes and errors in prescription writing | Selection of antibacterial drug(s) |
| Abbreviations | Important factors for choosing form, dose and |
| Poor prescriptions | course of antibiotics |
| Rational prescriptions | Importance of switching antibiotics based on |
| culture and antibiogram results | |
| Background | Pharmacology of antibiotic groups: |
| Epidemiology | ○ Betalactamases |
| Etiology | ○ Tetracyclines |
| Exaggeration of an intended pharmacologic | ○ Aminoglycosides |
| action of the drugs | ○ Macrolides |
| Toxicity unrelated to a drug's primary | ○ Fluoroquinolones |
| pharmacological activity: | ○ Sulfonamides |
| - Cytotoxic Reactions | |
| - Immunologic Mechanisms | A) Corticosteroids |
| Diagnosis and treatment of adverse drug | Indications |
| reactions | Emphasis on reducing injections |
| Adverse effects | |
| Important mechanisms of drug interactions | Important interactions |
| Common drug interactions in the practice of | B) Non steroidal anti inflammatory drugs |
| general physicians | (NSAIDs) |
| Indications | |
| Consideration of real needs for prescribing | Adverse effects |
| injections | Drug Interactions |
| Mechanism of injections | Contraindications |
| Indications for injections | |
| Important factors in prescribing injections | |
| Prevalence of prescribing injections in the | |
| world and in Iran |
* Numbers in parentheses refer to the related outcomes.